Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Clinical trials conducted in the early 2000s showed modest results, and the compound failed to demonstrate sufficient efficacy to support regulatory approval as a weight-loss medicine
TNF can promote insulin resistance in adipocytes (177), and FAs can activate JNK to promote the additional release of pro-inflammatory cytokines from macrophages (178) and adipocytes (179), inciting a vicious cycle
Daily intraperitoneal administration for 11 days reduced body weight gain, decreased white adipose tissue mass by approximately 35%, and reduced adipocyte size, while food intake between treated and control groups did not differ significantly
Targeted Fat Metabolism Unlike systemic weight loss agents, AOD-9604 works by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage) specifically in the areas where its applied, allowing for precise body contouring
US$ 26.99
US$ 22.41
US$ 22.96
US$ 26.05
US$ 22.99
US$ 21.65